CBRE

CBRE Group

$126.72

-1.25%
Nov 20, 2026
Bobby Quantitative Model
CBRE Group is the world's largest commercial real estate services and investment firm, generating revenue through advisory and brokerage, leasing, facilities and project management, valuation, mortgage servicing, and investment management across every major property type and more than 100 countries. Its scale, global footprint, and diversified service mix make it the industry's dominant platform rather than a niche specialist, with a workforce of roughly 155,000 and a market capitalization near $39-48 billion placing it firmly in large-cap territory. The current investor narrative centers on the October 2026 acquisition of Onnec Group, a strategic push into data center infrastructure that management frames as immediately accretive and directly levered to the AI-driven buildout, alongside a broader debate over whether commercial real estate transaction volumes are genuinely recovering after a prolonged rate-driven slump. That optimism is being tested against a stock that has badly lagged the market over the past year, with investors weighing cyclical recovery in leasing and capital markets activity against margin pressure and a still-elevated valuation relative to trailing earnings.

People also watch

Jones Lang LaSalle

Jones Lang LaSalle

JLL

Analysis
CoStar Group

CoStar Group

CSGP

Analysis
Compass RE

Compass RE

COMP

Analysis
Cushman & Wakefield

Cushman & Wakefield

CWK

Analysis
Opendoor

Opendoor

OPEN

Analysis

BobbyInvestment Opinion: Should I buy CBRE Today?

Rating: Buy (accumulate on weakness). The core thesis is that CBRE — the industry's dominant platform with 12 Buy ratings, 0 Sells, and a $170.25 average target implying 27.9% upside from $133.12 — is being priced on a depressed trailing earnings base (41.44x trailing PE) rather than on consensus forward EPS of $13.48, which yields a 14.98x forward PE that is genuinely cheap for a market leader. The Street's lowest target of $141.00 sits 5.9% above the current price, meaning no covering analyst sees downside from here.

Supporting evidence is concrete: Q3 2026 revenue of $11.517 billion grew 12.27% year-over-year with steady sequential expansion from $10.527 billion (Q1) to $11.226 billion (Q2) to $11.517 billion (Q3); Q3 net income of $443 million (3.85% net margin) more than doubled Q2's $204 million (1.82%); PS of 1.18x sits near the low end of its multi-year 2.9x-4.6x range; and the 1.82x PEG suggests the stock is priced roughly in line with growth rather than at a premium. The Onnec acquisition adds a structural AI data center growth vector that management frames as immediately accretive, and the stock's +3.30% one-month return with +5.56% relative strength versus SPY suggests a base is forming above the $121.44 low.

Three risks could invalidate the thesis: (1) gross margin of 18.45% in Q3 2026 trails the 19.40% posted a year earlier, so if margins stay compressed the $13.48 forward EPS is unreachable; (2) TTM free cash flow of $938 million on a $47.9 billion market cap is only a ~2.0% FCF yield, with Q1 2026 FCF of -$906 million showing heavy seasonality and debt-to-equity of 1.125; (3) beta of 1.227 and a -25.36% one-year relative strength gap versus SPY mean further sector rotation could extend the de-rating. This Buy would downgrade to Hold if Q4 gross margin falls below 18% or if forward EPS estimates are cut below $12.50, and would upgrade to a higher-conviction Buy if the stock reclaims $150 with margins expanding above 19%. On balance the stock is fairly valued on forward earnings and modestly undervalued relative to its own revenue-multiple history — not a deep-value bargain, but an attractive risk/reward for a cyclical recovery with a hard floor near $121.

Sign up to view all

CBRE 12-Month Price Forecast

The forward math is compelling: at 14.98x forward earnings CBRE trades at a discount to its own history and at a level that would be cheap for the industry's dominant platform, while the 41.44x trailing multiple simply reflects a trough earnings base. Revenue growth of 12.27% and the Q3 profitability step-up support the normalization thesis, and the absence of any Sell rating with a $141.00 floor target limits perceived downside. The offsetting evidence is real — gross margin compression versus a year ago, a thin ~2.0% FCF yield, and a -25.36% one-year relative strength gap versus SPY — which is why confidence is medium rather than high. I would upgrade to high confidence if Q4 gross margin recovers above 19% and forward EPS estimates hold at or above $13.48, and would downgrade to neutral if estimates are cut below $12.50 or the stock breaks decisively below $121.44.

Historical Price
Current Price $126.72
Average Target $160.13
High Target $200.00
Low Target $121.44

Wall Street consensus

Most Wall Street analysts maintain a constructive view on CBRE Group's 12-month outlook, with a consensus price target around $170.25 and implied upside of +34.4% versus the current price.

Average Target

$170.25

13 analysts

Implied Upside

+34.4%

vs. current price

Analyst Count

13

covering this stock

Price Range

$141 - $200

Analyst target range

Buy
12 (92%)
Hold
1 (8%)
Sell
0 (0%)

Coverage is solid with 12 analysts, and sentiment is decisively bullish: 12 Buy ratings, 1 Hold, and 0 Sells, for a recommendation mean of 1.54 and a consensus rating of "buy." The average target price of $170.25 implies roughly 27.9% upside from the current $133.12, a wide gap that signals the Street views the recent selloff as an overreaction rather than a fundamental deterioration. The consensus is clearly bullish, and the absence of any Sell ratings despite a 13% one-year decline suggests analysts are anchoring on forward earnings recovery and the data center acquisition catalyst.

The target range of $141.00 to $200.00 is wide, spanning about 42% from low to high, which signals meaningful disagreement about the pace of the commercial real estate recovery. The $200 high target likely assumes multiple expansion toward the historical mid-cycle range plus successful integration of Onnec and accelerating AI-driven data center demand, while the $141 low target—still above the current price—prices in only modest earnings normalization and continued margin pressure. Institutional ratings show a pattern of reaffirmations rather than fresh upgrades, with Evercore ISI, Keefe Bruyette & Woods, Barclays, and UBS all maintaining Outperform/Overweight/Buy stances through October 2026, indicating stable conviction but limited new positive catalysts; the tight clustering of reiterated ratings around a wide target range suggests analysts are waiting for confirmation from forward guidance before moving targets higher.

Drowning in data?

Find the real signal!

Bulls vs Bears: CBRE Investment Factors

The bear case currently has stronger near-term evidence: CBRE has lost 13.09% over one year against a market up 12.27%, sits in the bottom quartile of its 52-week range, and shows flat-to-compressed gross margins (18.45% vs 19.40% a year ago) that undercut the earnings recovery narrative. The bull case, however, is anchored in harder forward math — 12.27% revenue growth, a 14.98x forward PE on $13.48 consensus EPS, and unanimous analyst support with a $170.25 average target. The single most important tension is whether forward EPS of $13.48 is actually delivered: at 41.44x trailing earnings the stock has no cushion, but at 15x forward it is cheap for the industry's dominant platform. Resolution likely comes from the next two quarters of margin and transaction-volume data, plus evidence that Onnec's data center exposure is accretive as advertised.

Bullish

  • Analyst consensus firmly bullish with 28% upside: All 12 covering analysts rate CBRE a Buy (12 Buy, 1 Hold, 0 Sell) with a recommendation mean of 1.54 and an average target of $170.25, implying 27.9% upside from $133.12. Even the lowest target of $141.00 sits 5.9% above the current price, meaning the Street sees no downside case at today's level.
  • Forward PE of 15x vs 41x trailing: The trailing PE of 41.44x collapses to a forward PE of 14.98x on consensus EPS of $13.48, a multiple that would be genuinely cheap for a market-leading franchise. The gap signals the market is pricing a depressed earnings base rather than an inflated share price, and PS of 1.18x sits near the low end of its multi-year 2.9x-4.6x range.
  • Revenue reaccelerating at 12.3% YoY: Q3 2026 revenue of $11.517 billion grew 12.27% over Q3 2025's $10.258 billion, with sequential expansion from $10.527 billion in Q1 to $11.226 billion in Q2. Advisory services at $2.441 billion and project management at $2.035 billion are the core engines, supporting the thesis that transaction volumes are recovering.
  • Onnec acquisition adds AI data center exposure: The October 2026 acquisition of Onnec Group pushes CBRE into data center infrastructure, a market directly levered to the AI buildout, and management frames it as immediately accretive to earnings. This gives the company a structural growth vector beyond cyclical brokerage recovery.

Bearish

  • Severe underperformance and broken trend: CBRE is down 13.09% over one year and 16.90% YTD versus the S&P 500's +12.27% and +10.62%, a relative strength gap of -25.36% over one year. The stock sits at just 22% of its 52-week range ($121.44-$174.27) and only 9.6% above its low, with a -29.11% max drawdown confirming a de-rating.
  • Thin, volatile margins with no operating leverage: Operating margin is 3.19% (4.87% in Q3) and net margin swung from 1.82% in Q2 to 3.85% in Q3. Q3 gross margin of 18.45% is below the 19.40% posted in Q3 2025, indicating margins are stable-to-compressed rather than expanding — a direct threat to the forward EPS story.
  • Valuation rests entirely on forward delivery: At 22.02x EV/EBITDA, 5.40x price-to-book, 30.75x price-to-cash-flow and a 1.82x PEG, CBRE is not cheap on cash-based metrics. If the $13.48 forward EPS proves optimistic, the 41.44x trailing multiple offers little downside protection.
  • Weak cash conversion and leveraged balance sheet: TTM free cash flow of $938 million against a $47.9 billion market cap is a thin ~2.0% FCF yield, and cash flow is highly seasonal (Q1 2026 FCF of -$906 million). Debt-to-equity of 1.125 and a current ratio of just 1.095 mean the company leans on revolving credit to bridge working-capital gaps.

CBRE Technical Analysis

CBRE is in a corrective downtrend within a longer-term range, with the shares down 13.09% over the past year and 16.90% year-to-date, a stark underperformance versus the S&P 500's +12.27% one-year and +10.62% YTD returns. At $133.12, the stock sits at roughly 22% of its 52-week range of $121.44 to $174.27, meaning it is trading in the lower quartile of that band and only about 9.6% above its 52-week low. That positioning signals a stock that has been de-rated rather than one exhibiting momentum, and the -29.11% max drawdown confirms a meaningful peak-to-trough decline that has left the shares searching for a durable base rather than pressing new highs.

Short-term momentum has turned constructive even as the intermediate trend remains negative: the stock is up 3.30% over the past month and 2.44% over six months, but down 12.91% over three months, a clear divergence between a stabilizing one-month trend and a still-negative quarterly trajectory. That pattern is consistent with a mean-reversion bounce off the October lows near $121.65 rather than a confirmed trend reversal, and the relative strength figures reinforce the point: +5.56% versus SPY over one month but -10.08% over three months and -25.36% over one year. The recent rally from roughly $121 to $141 and back to $133 suggests buyers are defending the low-$120s, but the failure to hold above $140 indicates supply overhead remains heavy.

Key technical levels are well defined: support sits at the 52-week low of $121.44, with the October closing low of $121.65 reinforcing that zone, while resistance is anchored at the 52-week high of $174.27, with intermediate supply around the $150-$155 area where the stock repeatedly stalled in August and September. A decisive break below $121.44 would signal a fresh leg lower and likely trigger momentum-driven selling, whereas reclaiming $150 would mark the first meaningful higher-high structure of a potential recovery. With a beta of 1.227, CBRE is roughly 23% more volatile than the market, meaning position sizing should account for amplified drawdowns in risk-off episodes, and the modest short ratio of 1.64 suggests no meaningful bearish crowding to fuel a squeeze.

fundamental_analysis:

Beta

1.23

1.23x market volatility

Max Drawdown

-29.1%

Largest decline past year

52-Week Range

$121-$174

Price range past year

Annual Return

-16.4%

Cumulative gain past year

PeriodCBRE ReturnS&P 500
1m-5.9%-9.7%
3m-16.7%-9.9%
6m-3.3%-7.5%
1y-16.4%+4.7%
ytd-20.9%+1.2%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

CBRE Fundamental Analysis

Revenue is growing at a healthy clip, with Q3 2026 revenue of $11.517 billion up 12.27% year-over-year from $10.258 billion in Q3 2025, and the multi-quarter trend shows steady sequential expansion from $10.527 billion in Q1 to $11.226 billion in Q2 to $11.517 billion in Q3. The advisory services segment at $2.441 billion and project management at $2.035 billion are the core growth engines, while the much smaller real estate investments segment at $203 million remains a marginal contributor. Full-year consensus revenue of roughly $62.2 billion implies continued mid-single-to-low-double-digit expansion, and the trajectory supports the thesis that transaction and outsourcing activity is recovering, though the 12.27% growth rate is flattered by easy prior-year comparisons and should be watched for deceleration.

Profitability is positive but thin and volatile: Q3 2026 net income was $443 million on a 3.85% net margin and 18.45% gross margin, a sharp improvement from Q2's $204 million and 1.82% net margin but below Q1's $318 million at a 3.02% margin on a comparable basis. Operating margin of 3.19% (4.87% in Q3 specifically) is structurally low for a services business of this scale, reflecting the pass-through-heavy facilities management mix, and the quarterly swings in net margin from 1.82% to 3.85% show limited operating leverage. The Q3 gross margin of 18.45% compares favorably to Q4 2025's 15.29% but is below the 19.40% posted in Q3 2025, suggesting margins are stable-to-slightly-compressed rather than expanding, which is a key risk to the earnings growth story.

Balance sheet and cash flow are adequate but not fortress-like: debt-to-equity stands at 1.125, the current ratio is 1.095, and TTM free cash flow is $938 million against a $47.9 billion market cap, a thin FCF yield of roughly 2.0%. Cash flow is highly seasonal and lumpy, with Q1 2026 operating cash flow of -$825 million and free cash flow of -$906 million offset by Q3's +$869 million operating and +$743 million free cash flow, a pattern typical of working-capital-intensive brokerage. ROE of 13.03% and ROA of 2.40% are respectable for the industry but the 1.125 leverage ratio and modest 1.095 current ratio mean the company relies partly on external financing and revolving credit to bridge seasonal gaps, and the $1.82 billion cash balance provides a reasonable but not generous buffer.

valuation_overview:

Quarterly Revenue

$11.5B

2026-09

Revenue YoY Growth

+12.3%

YoY Comparison

Gross Margin

18.4%

Latest Quarter

Free Cash Flow

$938000000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Advisory Services Segment
Project Management
Real Estate Investments Segment

Open an Account, get $2 TSLA now!

Valuation Analysis: Is CBRE Overvalued?

Because CBRE is profitable (Q3 2026 net income of $443 million), the PE ratio is the appropriate primary metric, and the trailing PE of 41.44x stands in stark contrast to the forward PE of 14.98x. That enormous gap implies the market expects a dramatic earnings step-up, consistent with consensus EPS estimates of $13.48 for the forward period versus the trailing figure implied by the 41.44x multiple, and it means the stock's valuation case rests almost entirely on forward earnings delivery rather than current profitability.

Against the Real Estate sector, CBRE's 1.18x PS ratio and 1.07x EV/Sales are low on a revenue basis, but its 22.02x EV/EBITDA and 5.40x price-to-book are premium multiples that reflect the asset-light, fee-based nature of the services model rather than a capital-intensive REIT structure. The 1.82x PEG ratio suggests the stock is priced roughly in line with its growth rate rather than at a deep discount, and the 30.75x price-to-cash-flow multiple is elevated, indicating investors are paying up for cash generation that has yet to fully materialize. On balance the valuation is neither cheap nor egregiously expensive, but it offers little margin of safety if forward EPS estimates of $13.48 prove optimistic.

Historically, CBRE's PE has ranged widely, from roughly 12x-15x in 2022-2023 to 41x-60x during earnings troughs in 2024-2025, and the current 41.44x trailing multiple sits near the upper end of that band, consistent with a depressed earnings base rather than an inflated price. The PS ratio of 1.18x, by contrast, is near the low end of its multi-year range of roughly 2.9x-4.6x, a divergence that underscores how much the earnings denominator has compressed. The market is effectively pricing in a normalization of margins and transaction volumes; if that normalization stalls, the trailing multiple offers little downside protection, but if forward EPS of $13.48 is achieved, the 14.98x forward PE would represent a reasonable entry point for a market leader.

analyst_targets:

PE

41.4x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 12x~74x

vs. Industry Avg

27.2x

Industry PE ~27.2x*

EV/EBITDA

22.0x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on thin, volatile profitability and weak cash conversion. Operating margin of 3.19% and a Q3 net margin of 3.85% (versus 1.82% in Q2) show limited operating leverage in a pass-through-heavy facilities management mix, while Q3 gross margin of 18.45% trails the 19.40% of a year earlier. TTM free cash flow of $938 million on a $47.9 billion market cap is only a ~2.0% FCF yield, and cash flow is deeply seasonal — Q1 2026 operating cash flow was -$825 million against Q3's +$869 million. With debt-to-equity at 1.125 and a current ratio of 1.095, the company depends on revolving credit to bridge those gaps, and the $1.82 billion cash balance is adequate rather than generous. The entire valuation also hinges on forward EPS of $13.48 materializing; any shortfall would leave the 41.44x trailing multiple exposed.

Market and competitive risks are dominated by valuation compression and cyclical sensitivity. At 22.02x EV/EBITDA, 5.40x price-to-book and 30.75x price-to-cash-flow, CBRE trades at premium cash-based multiples that assume margin normalization; a stall in commercial real estate transaction recovery would compress those multiples quickly. The stock's beta of 1.227 makes it roughly 23% more volatile than the market, amplifying drawdowns in risk-off episodes, and its -25.36% one-year relative strength versus SPY shows how sharply sector rotation has already punished it. Recent news highlights both sides: the Onnec acquisition into AI data center infrastructure is a genuine growth vector, but February 2026 coverage of broad real estate selloffs and AI-driven market corrections shows how quickly sentiment can turn against the name. The wide $141-$200 analyst target range (42% spread) itself signals unresolved disagreement about the pace of recovery.

In a worst-case scenario, commercial real estate transaction volumes fail to recover, gross margins stay below 19%, and forward EPS of $13.48 proves unreachable — forcing analysts to cut targets and the market to re-rate the stock on trailing earnings. A retest of the 52-week low of $121.44 (reinforced by the October closing low of $121.65) would represent roughly -8.8% from $133.12, and a decisive break below that level would likely trigger momentum-driven selling toward the lower end of the historical multiple range. The -29.11% max drawdown is the relevant precedent for a full de-rating episode, implying a realistic adverse outcome of -9% to -29% from current levels, with the analyst low target of $141.00 offering no protection since it sits above the current price.

FAQ

Ranked by severity, the first risk is earnings-delivery risk: the 41.44x trailing PE leaves no cushion, and Q3 gross margin of 18.45% versus 19.40% a year earlier means the $13.48 forward EPS could prove optimistic if margins stay compressed. Second is cash flow and balance sheet risk — TTM free cash flow of $938 million is a thin ~2.0% yield, Q1 2026 free cash flow was -$906 million showing heavy seasonality, and debt-to-equity of 1.125 with a current ratio of just 1.095 means the company leans on revolving credit to bridge working-capital gaps. Third is cyclical and macro risk: commercial real estate transaction volumes have not convincingly recovered, beta of 1.227 amplifies drawdowns, and the stock has already lagged SPY by 25.36% over one year, so further sector rotation or an AI-driven market correction could extend the de-rating. Fourth is company-specific integration risk around Onnec, where unexpected costs or dilution could offset the promised accretion and remove a key pillar of the bull case.

The 12-month scenario framework assigns a 55% probability to the base case of $150.00-$170.25, in which revenue grows toward the $62.2 billion consensus, gross margin stabilizes near current levels, and forward EPS of $13.48 is broadly delivered, letting the stock grind toward the $170.25 average analyst target. The bull case carries 25% probability and a $174.27-$200.00 range, requiring transaction volumes to accelerate, gross margin to recover above 19%, visible Onnec accretion, and Fed rate cuts reviving capital markets activity. The bear case carries 20% probability and a $121.44-$141.00 range, triggered by a Q4 2026 earnings miss, margins stuck below 18.5%, and estimate cuts that force a re-rating on trailing earnings. The base case is most likely because it requires only modest normalization rather than a cyclical snapback, and the key assumption behind it is that forward EPS of $13.48 holds within the $13.11-$14.06 consensus band.

The answer depends entirely on which earnings base you trust. On trailing numbers CBRE looks expensive at 41.44x PE, 22.02x EV/EBITDA, 5.40x price-to-book and 30.75x price-to-cash-flow, but those multiples reflect a depressed earnings trough rather than an inflated price — the PS ratio of 1.18x actually sits near the low end of its multi-year 2.9x-4.6x range, confirming the denominator has collapsed. On forward consensus EPS of $13.48 the multiple drops to 14.98x, which is genuinely cheap for the industry's dominant platform, and the 1.82x PEG suggests the stock is priced roughly in line with growth rather than at a premium. The market is therefore pricing in margin and transaction-volume normalization; if that happens the stock is modestly undervalued, and if it stalls the trailing multiple offers little protection. Net verdict: fairly valued on forward earnings, modestly undervalued versus its own revenue-multiple history, but not a deep-value bargain.

From a risk/reward standpoint the setup is asymmetric in the buyer's favor: at $133.12 the stock trades 14.98x consensus forward EPS of $13.48, while the lowest of 13 analyst targets ($141.00) sits 5.9% above the current price and the average target of $170.25 implies 27.9% upside. The downside is quantifiable — a retest of the $121.44 52-week low is roughly -8.8%, and the -29.11% max drawdown marks the realistic worst case if margins stay compressed and forward estimates get cut. The catch is that the entire bull case rests on earnings delivery: Q3 gross margin of 18.45% was below the 19.40% posted a year earlier, and TTM free cash flow of $938 million is only a ~2.0% yield on the market cap. It is a good buy for investors with a 12-24 month horizon who want cyclical CRE recovery exposure with an AI data center kicker via Onnec, but it is not a low-volatility holding given beta of 1.227 and 13.09% one-year underperformance versus a market up 12.27%.

CBRE is better suited to a medium-to-long-term holding period of at least 12-24 months than to short-term trading. The recovery thesis — commercial real estate transaction volumes normalizing, margins stabilizing, and Onnec's data center exposure becoming accretive — is a multi-quarter story that will be validated or invalidated through successive earnings reports, and the stock's beta of 1.227 with a -29.11% max drawdown makes short-term price action highly unpredictable. There is no dividend (0% yield, 0 payout ratio) to compensate for waiting, so total return depends entirely on earnings delivery and multiple normalization toward the $170.25 consensus target. Earnings visibility is moderate rather than high, given the 42% spread between the $141.00 low and $200.00 high analyst targets and the fact that institutional actions have been reaffirmations rather than fresh upgrades. A patient investor with a 12-24 month horizon and tolerance for cyclical volatility is the natural holder; short-term traders should respect the $121.44 support level as their stop.